Choriogonadotropin Alfa 相關新聞

← 返回新聞總覽


Choriogonadotropin Alfa 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Choriogonadotropin Alfa 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Ovitrelle is indicated in the treatment of: women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF): Ovitrelle is administered to trigger final...
  • 證據等級:L5
  • 預測適應症(20 個):
    • peptic esophagitis(98.4%)
    • postural orthostatic tachycardia syndrome(98.3%)
    • esophageal disease(97.6%)
    • Raynaud disease(97.4%)
    • non-syndromic esophageal malformation(96.9%)
    • esophageal ulcer(96.8%)
    • His bundle tachycardia(96.0%)
    • sinoatrial block(95.9%)
    • progressive familial heart block(95.7%)
    • sinoatrial node disease(95.5%)
    • restless legs syndrome(95.4%)
    • esophageal atresia (disease)(95.3%)
    • active peptic ulcer disease(95.3%)
    • gastrojejunal ulcer(95.3%)
    • peptic ulcer perforation(95.3%)
    • migraine disorder(95.3%)
    • esophageal leukoplakia (disease)(95.2%)
    • acne (disease)(95.2%)
    • dyskinesia of esophagus(95.2%)
    • esophageal diverticulosis(95.2%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.